Eureka delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

ISO 10993-5 Extract Preparation: Polar vs. Non-Polar Solvents

JUL 25, 2025 |

**Introduction to ISO 10993-5**

ISO 10993-5 is a crucial standard within the ISO 10993 series, focusing on the biological evaluation of medical devices. Specifically, it deals with tests for in vitro cytotoxicity. The primary objective is to determine the potential toxic effects that medical devices might have on cells. Among various parameters, the preparation of extracts from medical devices using different solvents plays a significant role in assessing biocompatibility. The choice between polar and non-polar solvents for extract preparation is critical, as it directly influences the accuracy and reliability of cytotoxicity testing.

**Understanding Polar and Non-Polar Solvents**

Solvents are categorized into polar and non-polar based on their ability to dissolve substances. Polar solvents, such as water and ethanol, have molecules with a substantial difference in electronegativity between atoms, resulting in partial positive and negative charges. This makes them highly effective at dissolving ionic and other polar substances. Conversely, non-polar solvents, such as hexane and toluene, consist of molecules that do not have significant charge differences, making them suitable for dissolving non-polar substances.

**Role of Solvents in Extract Preparation**

The choice of solvent in the extraction process is crucial because it determines which compounds are leached from the medical device into the extract. Different solvents interact with the materials of the device in unique ways, potentially dissolving various constituents. Polar solvents may extract hydrophilic (water-attracting) compounds, while non-polar solvents are more effective in extracting hydrophobic (water-repelling) substances. Using both types of solvents allows for a comprehensive evaluation of the potential cytotoxicity of various constituents that a medical device might release.

**Polar Solvents in Extract Preparation**

Polar solvents often serve as the primary choice when preparing extracts for cytotoxicity testing because they simulate the aqueous environment of the human body. Water, being the most common polar solvent, is frequently used to identify substances that are likely to dissolve in bodily fluids. Ethanol is another polar solvent used for its ability to dissolve a broader range of compounds than water alone. The use of polar solvents is particularly important when evaluating devices that will come into contact with blood or other aqueous body fluids, as it provides insights into potential interactions.

**Non-Polar Solvents in Extract Preparation**

Non-polar solvents, like hexane, are employed to target hydrophobic substances in a medical device. These solvents are particularly useful when testing materials that might be exposed to non-aqueous environments in the body or in situations where non-polar substances could leach out under specific conditions. Using non-polar solvents helps identify potential toxic risks associated with compounds that might not be detected through polar solvent extraction alone.

**Balancing Both Solvent Types**

For a comprehensive cytotoxicity evaluation, it's often necessary to use both polar and non-polar solvents. This dual approach ensures that the full spectrum of extractable substances is assessed, providing a more complete picture of the potential biological impact. By leveraging the different strengths of each solvent type, researchers can better predict how a medical device will perform in the complex environment of the human body.

**Conclusion**

The preparation of extracts using polar and non-polar solvents is a critical factor in the biological evaluation of medical devices under ISO 10993-5. Understanding the distinct roles and applications of these solvents is essential for accurate cytotoxicity testing. By carefully selecting solvents, researchers can ensure that all potentially harmful substances are detected, thereby safeguarding patient health and enhancing the overall safety and effectiveness of medical devices.

From next-generation membrane materials to high-efficiency separation processes for pharmaceuticals, water treatment, food processing, or energy systems, the filtration & separation industry is rapidly evolving with a surge in material innovation, microstructure design, and process optimization.

Patsnap Eureka, our intelligent AI assistant built for R&D professionals in high-tech sectors, empowers you with real-time expert-level analysis, technology roadmap exploration, and strategic mapping of core patents—all within a seamless, user-friendly interface.

Whether you're designing the next high-throughput filter, optimizing nanostructured surfaces, or exploring new separation media for emerging industries—Patsnap Eureka gives you AI-driven insights in seconds, helping you move from ideation to innovation with confidence.

🚀 Start your free trial today and experience how Eureka transforms filtration innovation—from reactive to predictive.

图形用户界面, 文本, 应用程序

描述已自动生成

图形用户界面, 文本, 应用程序

描述已自动生成

Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More